Published in Mol Ther on August 07, 2013
Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One (2014) 0.91
New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci Rep (2013) 0.89
Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium. PLoS One (2014) 0.85
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics (2015) 0.82
Isolation and Characterization of a Monobody with a Fibronectin Domain III Scaffold That Specifically Binds EphA2. PLoS One (2015) 0.80
RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics (2016) 0.77
Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential. Oncotarget (2016) 0.76
Targeted Cancer Therapy Using Engineered Salmonella typhimurium. Chonnam Med J (2016) 0.75
The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma. Onco Targets Ther (2015) 0.75
Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy. PLoS One (2015) 0.75
Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system. Cancer Biol Ther (2016) 0.75
Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis. Sci Rep (2016) 0.75
Pseudomonas aeruginosa mannose-sensitive hemagglutinin inhibits proliferation and invasion via the PTEN/AKT pathway in HeLa cells. Oncotarget (2016) 0.75
L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors. Mol Ther Oncolytics (2015) 0.75
Salmonella-Mediated Cancer Therapy: Roles and Potential. Nucl Med Mol Imaging (2016) 0.75
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol (1995) 46.37
Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer (2002) 7.79
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol (2002) 4.15
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol (1999) 3.97
Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell (2003) 3.88
Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res (1997) 3.45
Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol (2004) 3.36
Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel (2006) 3.27
Regulation of bacterial drug export systems. Microbiol Mol Biol Rev (2002) 3.00
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci U S A (2005) 2.76
Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer (2010) 2.70
Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A (2001) 2.62
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res (2006) 2.51
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A (2007) 2.46
Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle (2009) 2.28
Bacteria-mediated delivery of nanoparticles and cargo into cells. Nat Nanotechnol (2007) 1.83
Bacteria as tumour-targeting vectors. Lancet Oncol (2003) 1.78
Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res (2009) 1.76
Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem (2009) 1.73
In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods (2007) 1.64
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci U S A (2001) 1.59
Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle (2012) 1.44
Biological gene delivery vehicles: beyond viral vectors. Mol Ther (2009) 1.43
Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res (2008) 1.42
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem (2004) 1.41
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J Clin Invest (2006) 1.41
Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res (2003) 1.40
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res (2009) 1.38
Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol (2008) 1.37
Antitumor effect of Bifidobacterium infantis in mice. Gan (1978) 1.35
Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol (2007) 1.31
Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci U S A (2007) 1.24
Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc (2008) 1.22
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol (2007) 1.21
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol (2007) 1.16
Mouse models for tumor metastasis. Methods Mol Biol (2012) 1.13
Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther (2010) 1.12
Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Gene Ther (2001) 1.05
Whole-body imaging of bacterial infection and antibiotic response. Nat Protoc (2006) 1.04
Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc Natl Acad Sci U S A (1999) 1.04
Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect (2009) 0.99
Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst (2008) 0.99
In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother (1990) 0.98
Posttranscriptional control of the Salmonella enterica flagellar hook protein FlgE. J Bacteriol (2006) 0.97
Production of protein complexes via co-expression. Protein Expr Purif (2010) 0.91
Improved mycobacterial tetracycline inducible vectors. Plasmid (2010) 0.90
Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. Appl Environ Microbiol (2001) 0.86
Engineering and visualization of bacteria for targeting infarcted myocardium. Mol Ther (2011) 0.84
Shedding light onto live molecular targets. Nat Med (2003) 8.47
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med (2011) 7.82
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect Immun (2003) 2.69
In vivo imaging of proteolytic activity in atherosclerosis. Circulation (2002) 2.62
A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys (2003) 2.58
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation (2006) 2.56
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation (2008) 2.52
Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med (2011) 2.44
Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation (2003) 2.37
Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt (2010) 2.34
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis (2009) 2.26
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation (2007) 2.19
Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci U S A (2005) 2.16
Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized Born ratio. IEEE Trans Med Imaging (2005) 2.15
Does whole-spine lateral radiograph with clavicle positioning reflect the correct cervical sagittal alignment? Eur Spine J (2014) 2.09
Multispectral photoacoustic imaging of fluorochromes in small animals. Opt Lett (2007) 2.04
Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer. Eur J Nucl Med Mol Imaging (2012) 2.04
CD133 mRNA expression and microsatellite instability in colorectal carcinoma. J Surg Oncol (2010) 2.02
Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci U S A (2008) 2.00
Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J Biomed Opt (2008) 1.93
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci U S A (2005) 1.91
Free-space fluorescence molecular tomography utilizing 360 degrees geometry projections. Opt Lett (2007) 1.91
Tomographic fluorescence mapping of tumor targets. Cancer Res (2005) 1.89
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol (2010) 1.89
Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol (2002) 1.87
Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol (2002) 1.83
Genome sequence of the polymyxin-producing plant-probiotic rhizobacterium Paenibacillus polymyxa E681. J Bacteriol (2010) 1.82
Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. Radiology (2012) 1.81
In vivo imaging of Drosophila melanogaster pupae with mesoscopic fluorescence tomography. Nat Methods (2007) 1.78
Volumetric real-time multispectral optoacoustic tomography of biomarkers. Nat Protoc (2011) 1.78
Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system. Mol Microbiol (2003) 1.76
Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography. J Opt Soc Am A Opt Image Sci Vis (2004) 1.65
Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol (2007) 1.64
A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun (2006) 1.63
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med (2011) 1.62
Experimental fluorescence tomography of tissues with noncontact measurements. IEEE Trans Med Imaging (2004) 1.62
Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging (2009) 1.62
Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med Mycol (2010) 1.61
Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol (2011) 1.60
Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med (2011) 1.54
Fast semi-analytical model-based acoustic inversion for quantitative optoacoustic tomography. IEEE Trans Med Imaging (2010) 1.52
Fluorescent protein expression driven by her4 regulatory elements reveals the spatiotemporal pattern of Notch signaling in the nervous system of zebrafish embryos. Dev Biol (2006) 1.52
Multispectral imaging using multiple-bandpass filters. Opt Lett (2008) 1.52
Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol (2011) 1.50
Time-resolved imaging of optical coefficients through murine chest cavities. J Biomed Opt (2007) 1.46
Identification and functional analysis of the fusaricidin biosynthetic gene of Paenibacillus polymyxa E681. Biochem Biophys Res Commun (2007) 1.45
Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology (2007) 1.45
[Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital]. Korean J Lab Med (2009) 1.44
FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography. Nat Methods (2012) 1.44
Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques. J Biomed Opt (2010) 1.42
Condyloma accuminatum treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18). J Am Acad Dermatol (2011) 1.42
ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. J Biol Chem (2004) 1.41
Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol (2011) 1.41
DNA looping-mediated repression by histone-like protein H-NS: specific requirement of Esigma70 as a cofactor for looping. Genes Dev (2005) 1.38
Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. J Clin Microbiol (2007) 1.38
Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Res (2009) 1.38
High-sensitivity compact ultrasonic detector based on a pi-phase-shifted fiber Bragg grating. Opt Lett (2011) 1.35
Fluorescent protein tomography scanner for small animal imaging. IEEE Trans Med Imaging (2005) 1.34
Genomic blueprint of Hahella chejuensis, a marine microbe producing an algicidal agent. Nucleic Acids Res (2005) 1.34
Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation (2004) 1.33
Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis. J Bacteriol (2009) 1.33
Multispectral optoacoustic tomography (MSOT) scanner for whole-body small animal imaging. Opt Express (2009) 1.30
Complete-angle projection diffuse optical tomography by use of early photons. Opt Lett (2005) 1.30
Real-time imaging of cardiovascular dynamics and circulating gold nanorods with multispectral optoacoustic tomography. Opt Express (2010) 1.30
Free-space propagation of diffuse light: theory and experiments. Phys Rev Lett (2003) 1.28
Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology (2003) 1.28
Compressive sensing for biomedical imaging. IEEE Trans Med Imaging (2011) 1.27
Video rate optoacoustic tomography of mouse kidney perfusion. Opt Lett (2010) 1.25
Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Eur J Cancer (2011) 1.23
Noncontact optical imaging in mice with full angular coverage and automatic surface extraction. Appl Opt (2007) 1.23
Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol (2005) 1.22
Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc (2008) 1.22
Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol Imaging Biol (2012) 1.22
Development of fluorescent materials for Diffuse Fluorescence Tomography standards and phantoms. Opt Express (2007) 1.22
PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol. J Biol Chem (2004) 1.22
Performance dependence of hybrid x-ray computed tomography/fluorescence molecular tomography on the optical forward problem. J Opt Soc Am A Opt Image Sci Vis (2009) 1.20
Genetic diversity among Korean Candida albicans bloodstream isolates: assessment by multilocus sequence typing and restriction endonuclease analysis of genomic DNA by use of BssHII. J Clin Microbiol (2011) 1.20
Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings. Ann Nucl Med (2009) 1.19
Hybrid photoacoustic fluorescence molecular tomography using finite-element-based inversion. Med Phys (2007) 1.19
Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett (2002) 1.19
Optimization of 360 degrees projection fluorescence molecular tomography. Med Image Anal (2007) 1.18
Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. Neoplasia (2003) 1.18
Normalized Born ratio for fluorescence optical projection tomography. Opt Lett (2009) 1.17
Fluorescence molecular tomography in the presence of background fluorescence. Phys Med Biol (2006) 1.16
Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli. Mol Imaging Biol (2007) 1.16
Noncontact optical tomography of turbid media. Opt Lett (2003) 1.16
The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology (2011) 1.16
Three-dimensional optoacoustic tomography using a conventional ultrasound linear detector array: whole-body tomographic system for small animals. Med Phys (2013) 1.16
Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol Imaging (2007) 1.15
The active site of cellobiohydrolase Cel6A from Trichoderma reesei: the roles of aspartic acids D221 and D175. J Am Chem Soc (2002) 1.15